文献速递冠心病心力衰竭与心肌病心律失常

战术运动员心血管异常照护的临床考量:ACC/AHA科学声明

Clinical Considerations for the Care of the Tactical Athlete With Cardiovascular Abnormalities: A Scientific Statement From the American College of Cardiology and the American Heart Association.
PubMed 文献 · Circulation · 2026-09-03

该科学声明由美国心脏病学会(ACC)与美国心脏协会(AHA)联合制定,旨在为照护患有心血管疾病或存在心血管疾病风险的战术运动员(消防员、执法人员、军人)的临床医生及监管组织提供指导。声明围绕职业需求与适岗评估的交互作用,分11个章节阐述各心血管疾病领域的临床考量,并附临床考量表格。

要点

  • 战术运动员的心血管评估需结合职业任务需求与适岗评估,讨论心血管事件对队友、社区安全及任务成功的影响。
  • 声明涵盖心肌病、心肌炎、先天性心脏病、主动脉病、心律失常、通道病等11个章节的临床考量。
  • 各章节提供临床考量表格,供临床医生参考。

核心结论

  • 为战术运动员心血管异常的照护提供基于职业需求与适岗评估的临床考量框架。

研究设计与样本

  • ACC/AHA科学声明,由战术运动员领域、运动心脏病学及相关主题专家组成工作组,分11个章节撰写,基于综合文献综述及可用的战术运动员聚焦数据。

关键数值与推荐

  • 声明包含11个章节:战术任务分类、赛前心脏评估、伦理法律方面、遗传性心肌病、心肌炎及其他获得性心脏病、先天性心脏病、主动脉病/二叶式主动脉瓣/自发性冠状动脉夹层、晕厥/心脏骤停/心律失常/装置、心脏通道病、老年战术运动员、环境暴露/表现增强药物/补充剂及其他心脏状况与考量。

临床怎么用

  • 临床医生可参考各章节的临床考量表格,对战术运动员进行心血管风险评估和适岗评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: The American College of Cardiology/American Heart Association Scientific Statement, "Clinical Considerations for the Care of the Tactical Athlete With Cardiovascular Abnormalities," was written to provide guidance and education for clinicians caring for the tactical athlete (ie, firefighters, law enforcement officers, military) with cardiovascular disease or risk for cardiovascular disease, and for the organizations overseeing the care and wellness of these athletes. The considerations are shaped by the interaction between occupational demands and fit for full duty assessments, including risk discussions about how a cardiovascular event in a tactical athlete could impact teammates' well-being, community safety, and overall mission success. METHODS: This scientific statement is organized into 11 sections focused on cardiovascular disease processes and other topics that are relevant when considering the potential risks and benefits of performing tasks specific to the tactical athlete. Task forces, comprised of experts in tactical athlete domains, sports cardiology, and the respective topics covered, were assigned to each section, and specific "Clinical Considerations Tables" for clinicians to reference were prepared. Comprehensive literature reviews and an emphasis on tactical athlete-focused data, as available, were integral in the writing of all clinical considerations presented. The framework mirrors that of the recently published, "Clinical Considerations for Competitive Sports Participation for Athletes With Cardiovascular Abnormalities: A Scientific Statement From the American Heart Association and American College of Cardiology." STRUCTURE: The specific sections in this document include: Section 1: Tactical Tasks Classification; Section 2: The Tactical Athlete Preparticipation Cardiac Evaluation; Section 3: Ethical and Legal Aspects of Tactical Clinical Management; Section 4: Genetic Cardiomyopathies; Section 5: Myocarditis and Other Acquired Cardiac Conditions; Section 6: Congenital Heart Disease; Section 7: Aortopathy, Bicuspid Aortic Valve, and Spontaneous Coronary Artery Dissection; Section 8: Syncope, SCA, Arrhythmias, and Devices; Section 9: Cardiac Channelopathies; Section 10: Older Tactical Athlete; Section 11: Environmental Exposures, PED/S, and Additional Cardiac Conditions and Considerations. Each section provides a summary detailing the rationale for key clinical considerations and the respective Clinical Considerations Table(s).

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Dineen EH, Haigney MC, Levine BD, et al. Clinical Considerations for the Care of the Tactical Athlete With Cardiovascular Abnormalities: A Scientific Statement From the American College of Cardiology and the American Heart Association. Circulation. 2026. PMID: 42691142. doi:10.1161/CIR.0000000000001476

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。